Wells Fargo Downgrades Myriad Genetics (MYGN) to Market Perform

August 10, 2016 7:03 AM EDT
Get Alerts MYGN Hot Sheet
Price: $17.31 +0.93%

Rating Summary:
    7 Buy, 16 Hold, 6 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 17 | Down: 27 | New: 28
Trade MYGN Now!
Join SI Premium – FREE

Find out which companies are about to raise their dividend well before the news hits the Street with StreetInsider.com's Dividend Insider Elite. Sign-up for a FREE trial here.

Wells Fargo downgraded Myriad Genetics (NASDAQ: MYGN) from Outperform to Market Perform.

For an analyst ratings summary and ratings history on Myriad Genetics click here. For more ratings news on Myriad Genetics click here.

Shares of Myriad Genetics closed at $29.46 yesterday.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Downgrades

Related Entities

Wells Fargo

Add Your Comment